MedPath

Study of investigation tools in COVID 19 patients anx how it affects on patients outcome

Not yet recruiting
Conditions
Coronavirus as the cause of diseases classified elsewhere,
Registration Number
CTRI/2021/06/034352
Lead Sponsor
GCS medical college and hospital centre
Brief Summary

This study is allaboutthe correlation of biomarkers in covid 19 patients with patients outcome. This study aims to explore the different serum biomarkers role including il6, crp, pct, s. Ferritin, s. Ldh. In the disease pathogenesis of covid19 and assess how their levels vary depending on the severityof the disease and how they affect overall outcome of the patient. The objective of the study is to determine mortality rate in covid 19 patients. This is a hospital based longitudinal study and type of the study is observational.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

all age group, both sexes,including covid 19 rtpcr or hrct positive patients those who give consent for participation.

Exclusion Criteria

including all covid 19 patients those who refuse to give consent and who took dama as their outcomes are not favorable.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
correlation of the diagnostic and prognostic value of the serum biomarkers related to pandemic covid 19and assess the severity of its outcome s in current populationAt the end of 8 weeks
Secondary Outcome Measures
NameTimeMethod
to determine the mortality rate in covid 19 patientsAt the end of 8 weeks

Trial Locations

Locations (1)

Department of TB & Chest, GCS Medical College, hospital and Research Centre

🇮🇳

Ahmadabad, GUJARAT, India

Department of TB & Chest, GCS Medical College, hospital and Research Centre
🇮🇳Ahmadabad, GUJARAT, India
naman patel
Principal investigator
7575020539
npatel5887@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.